A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

933

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

August 19, 2026

Study Completion Date

December 12, 2026

Conditions
Advanced Solid Tumors
Interventions
DRUG

REGN7075

Intravenous (IV) infusion or subcutaneous (SC) injection will be administered every week (QW) or every 3 weeks (Q3W)

DRUG

Cemiplimab

Administered concomitantly Q3W by IV infusion or SC injection

DRUG

Platinum-based doublet chemotherapy

Administered IV Q3W

DRUG

Bevacizumab

Administered per protocol

DRUG

Trifluridine-tipiracil

Administered per protocol

Trial Locations (50)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

21034

RECRUITING

Centre Georges Francois Leclerc, Dijon

28040

RECRUITING

Hospital Clinico San Carlos, Madrid

RECRUITING

Hospital Universitario Fundacion Jimenez Diaz, Madrid

RECRUITING

Hospital Clinico Universitario - University of Valencia, Valencia

28041

RECRUITING

Hospital 12 de Octubre, Madrid

28223

RECRUITING

Hospital Universitario Quiron Salud Madrid, Pozuelo de Alarcón

31059

RECRUITING

Institut Claudius Regaud, IUCT-Oncopole, Toulouse

32610

RECRUITING

University of Florida Health, Gainesville

33076

RECRUITING

Institut Bergonie, Bordeaux

33612

COMPLETED

Moffitt Cancer Center, Tampa

34450

RECRUITING

Istanbul University Cerrahpasa at Cerrahpasa Medical Faculty, Istanbul

37203

RECRUITING

Sarah Cannon Research Institute - 25th Ave, Nashville

45219

RECRUITING

University of Cincinnati Medical Center, Cincinnati

49546

RECRUITING

START Midwest - Cancer & Hematology Centers of Western Michigan, PC, Grand Rapids

52240

RECRUITING

University of Iowa Hospitals and Clinics, Iowa City

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

60612

RECRUITING

University of Illinois Cancer Center, Chicago

63011

RECRUITING

Centre Jean Perrin, Clermont-Ferrand

64239

RECRUITING

Tel Aviv Sourasky Medical Center, Tel Aviv

69008

RECRUITING

Centre Leon Berard (CLB) - Centre de Recherche en Cancerologie Lyon-Est (CRCL), Lyon

69310

RECRUITING

Hopital Lyon Sud, Pierre-Bénite

77030

RECRUITING

MD Anderson Cancer Center, Houston

78229

COMPLETED

South Texas Oncology And Hematology, San Antonio

80045

RECRUITING

University of Colorado Hospital - Anschutz Cancer Pavilion - Lung Cancer Clinic, Aurora

81450

RECRUITING

Istanbul Medeniyet University - Prof Dr Suleyman Yalcin Sehir Hospital, Istanbul

84101

RECRUITING

Soroka University Medical Center, Beersheba

86021

RECRUITING

Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers

90067

RECRUITING

Valkyrie Clinical Trials, Los Angeles

90095

RECRUITING

University of California Los Angeles (UCLA) Medical Center, Los Angeles

91220

RECRUITING

Hadassah Medical Center, Jerusalem

94118

RECRUITING

The Regents of the University of California, San Francisco, San Francisco

94240

RECRUITING

Begin Army Instruction Hospital, Saint-Mandé

94800

RECRUITING

Gustave Roussy, Villejuif

3109601

RECRUITING

Rambam Health Care Campus, Haifa

5265601

RECRUITING

Sheba Medical Center, Ramat Gan

9103102

RECRUITING

Shaare Zedek Medical Center, Jerusalem

02215

WITHDRAWN

Dana Farber Cancer Institute Brookline Avenue, Boston

08901

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

43212-3117

COMPLETED

The Stefanie Spielman Comprehensive Breast Center, Columbus

06189

RECRUITING

Centre Antoine Lacassagne, Nice

1066 CX

RECRUITING

Netherlands Cancer Institute, Amsterdam

3015 GD

RECRUITING

Erasmus MC, Rotterdam

60-693

RECRUITING

Medpolonia Sp. z o.o., Poznan

70-784

RECRUITING

Dom Lekarski SA, Szczecin

08195

RECRUITING

Hospital General de Catalunya, Sant Cugat del Vallès

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

01120

RECRUITING

Baskent Universitesi, Yüreğir

06200

RECRUITING

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY